Axsome Therapeutics (AXSM) Other Non Operating Income (2015 - 2025)
Axsome Therapeutics recorded quarterly Other Non Operating Income of -$10.4 million in Q2 2025, down 732.79% quarter-over-quarter from -$1.2 million in Q3 2020.
Axsome Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$10.4 million for Q2 2025.
- In Q2 2025, Other Non Operating Income changed N/A year-over-year to -$10.4 million; the TTM figure through Dec 2025 stood at -$10.4 million (changed N/A YoY), while the FY2025 annual figure was -$10.4 million, changed N/A from the prior year.
- Other Non Operating Income came in at -$10.4 million for Q2 2025 at Axsome Therapeutics, down from -$1.2 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of -$10.4 million in Q2 2025 to a low of -$10.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -10.39 Mn |
| Sep 30, 2020 | -1.25 Mn |
| Dec 31, 2015 | -2.72 Mn |
| Sep 30, 2015 | 204,000.00 |
| Jun 30, 2015 | 149,900.00 |
| Mar 31, 2015 | -79,100.00 |